Evidence map›Paper›PMID 34575088›Full record

ArticleLife (Basel, Switzerland)2021

Antithrombotic Effect of the Ethanol Extract of

Pia Loreto Werlinger Bravo, Hui Jin, Hyunwoo Park, Min Sang Kim, Hirofumi Matsui, Hanki Lee, Joo-Won Suh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. SHProInvestigative and clinical urology · 2025
    Trial
  2. Article
  3. Immune-enhancement effects ofFood science and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Pia Loreto Werlinger BravoGraduate School of Interdisciplinary Program of Biomodulation, Myongji University, Yongin 17058, Korea.
Hui JinCenter for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin 17058, Korea.
Hyunwoo ParkCenter for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin 17058, Korea.
Min Sang KimCenter for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin 17058, Korea.ORCID 0000-0003-1242-0929
Hirofumi MatsuiGraduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan.
Hanki LeeGraduate School of Interdisciplinary Program of Biomodulation, Myongji University, Yongin 17058, Korea.
Joo-Won SuhCenter for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin 17058, Korea.
Myongji University · KRKagoshima University · JP

Funding

Rural Development Administration, Republic of Korea Cooperative Research Program for Agriculture Science & Technology Development (PJ01561701)
6 · The paper itself

Abstract

Cardiovascular diseases, such as stroke, are the most common causes of death in developed countries. Ischemic stroke accounts for 85% of the total cases and is caused by abnormal thrombus formation in the vessels, causing deficient blood and oxygen supply to the brain. Prophylactic treatments include the prevention of thrombus formation, of which the most used is acetylsalicylic acid (ASA); however, it is associated with a high incidence of side effects.

Indexed as

acetylsalicylic acidAngelica gigas Nakaianti-platelet aggregationbleeding in the gutimprovement of blood circulationside effectthrombus formation

Identifiers

PMID34575088
PMCPMC8465650
OpenAlexW3197610509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.